Neozolid
Neozolid 250 600mg Tablets
Composition:
Each film coated tablet contains:
Active ingredients:
Azithromycin dihydrate ……………………… 262 mg
(Equivalent to Azithromycin anhydrous 250 mg)
Azithromycin dihydrate ……………………… 628.8 mg
(Equivalent to Azithromycin anhydrous 600 mg)
Indications:
Neozolid 250 film coated tablets is indicated for the following bacterial infections induced by microorganisms susceptible to azithromycin:
- Acute bacterial sinusitis (adequately diagnosed)
- Acute bacterial otitis media (adequately diagnosed)
- Pharyngitis, tonsillitis
- Acute exacerbation of chronic bronchitis (adequately diagnosed)
- Mild to moderately severe community acquired pneumonia
- Infections of the skin and soft tissues of mild to moderate severity e.g. folliculitis, cellulitis, erysipelas
- Uncomplicated Chlamydia trachomatis urethritis and cervicitis
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Neozolid 600mg film coated tablets is indicated for the following bacterial
infections induced by microorganisms susceptible to azithromycin:
- Lower respiratory tract infections: Community-acquired pneumonia, acute bacterial exacerbation of chronic obstructive pulmonary diseases, acute bronchitis due to Haemophilus influenzae, Moraxella catrarrhalis or Streptococcus
- Upper respiratory tract infections: Ear, nose and throat infections like tonsillitis, sinusitis, otitis media and pharyngitis.
- Skin or skin structure and soft tissue infections: Furunculosis and impetigo due to Staphylococcus aureus, pyogenes ors. agalactiae.
- Sexually transmitted diseases: due to N. gonorrhoeae and Chlamydia trachomatis. Concurrant infection with Treponema pallidum should be excluded. Neozoid 600 mg Tablets may be also used in treatment of Mycobacterium avium complex (MAC) infections and in toxoplasmosis encephalitis.